RE:RE:RE:RE:RE:RE:RE:RE:RE:Wally Fan club I agree mrna definitely isn't a threat at the moment. They have to first understand what gene to fix before they can work on a solution. When they do they can potentially stop TD1 before it starts. This however won't help those with td1, they will still be looking for treatment. It could still be another decade before we find out the cause of TD1. In the mean time a functional cure will be very valuable to those who need treatment. I believe Moderna was doing mrna trials to grow blood vessels to help diabetes regain circulation? This seems plausible. As for valuations 2$ would be incredibly cheap the only way I could see that is if Philip wanted out now and had the support to accept a lowball offer. It's possible but I feel he has his sights on something bigger.